Hirsch G M, Karnovsky M J
Department of Pathology, Harvard Medical School, Boston, MA 02115.
Am J Pathol. 1991 Sep;139(3):581-7.
The authors investigated the effect of heparin on the development of myointimal proliferative lesions in a rat vein graft model. Intimal thickening in this model was most pronounced in the anastomotic regions, and was composed principally of vascular smooth muscle cells, as identified by immunocytochemistry with anti-muscle actin antibody, HHF-35. Medial thickening was less cellular, and evenly distributed throughout the grafts. Continuous, intravenous infusion of whole heparin at 0.3 mg/kg/hr effectively inhibited the development of myointimal proliferative lesions, although with no effect on medial thickening. The authors suggest that heparin, through its antiproliferative activity for vascular smooth muscle cells, may have a potentially important pharmacologic role in preventing vein graft failure, which most commonly results from the development of myointimal proliferative lesions.
作者在大鼠静脉移植模型中研究了肝素对肌内膜增生性病变发展的影响。该模型中的内膜增厚在吻合区域最为明显,主要由血管平滑肌细胞组成,通过用抗肌动蛋白抗体HHF - 35进行免疫细胞化学鉴定。中膜增厚的细胞较少,且均匀分布于整个移植物中。以0.3mg/kg/hr的剂量持续静脉输注全肝素可有效抑制肌内膜增生性病变的发展,尽管对中膜增厚没有影响。作者认为,肝素通过其对血管平滑肌细胞的抗增殖活性,可能在预防静脉移植失败方面具有潜在的重要药理作用,静脉移植失败最常见的原因是肌内膜增生性病变的发展。